NeuroWave nets FDA approval for device that monitors brain activity during anesthesia


NeuroWave Systems Inc. has announced that it’s been awarded clearance by the U.S. Food and Drug Administration for its NeuroSENSE® NS-901 Monitor.

The Beachwood medical equipment manufacturer describes the product as a “new generation brain function monitor for assessing the adequacy of anesthesia and sedation in clinical settings.”

It basically helps clinicians in the monitoring of brain functions in anesthetized patients (specifically adults 18 and older).

Click here to read the complete story.

Story excerpt provided by Crain’s Cleveland Business.

Originally published September 29, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: